(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)methanamine hydrochloride, 95.0%, 250mg

Ethyl 4-chloro-2-methylpyrimidine-5-carboxylate, 95.0%, 250mg

4-Bromophenoxyacetic Acid>98.0%(GC)(T)5g

(S)-Tert-butyl 3,3-difluoro-4-hydroxypiperidine-1-carboxylate, 97%, 500mg

D(+)-raffinose pentahydrate, min. 98%, for biochemistry, 250 g, plastic packaging.

1-Bromo-4-(2-methoxyethoxy)benzene, 95.0%, 5g

2-Isopropoxypyridine, 95.0%, 5g

3-(4,6-Dimethoxypyrimidin-2-yl)aniline, 95.0%, 5g

3-Amino-5-phenylbenzoic acid, 98%, 1g

2-((tert-Butoxycarbonyl)(methyl)amino)propanoic acid, 95.0%, 100g

[4-(trifluoromethyl)phenyl]urea, 250mg

3-(2-fluorophenyl)-1,2-oxazol-5-ol, 95.0%, 10g

N-(3-cyanophenyl)-N-(4-methoxyphenyl)amine, 97.0%, 1g